Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

55.08
Delayed Data
As of May 03
 -0.22 / -0.40%
Today’s Change
45.69
Today|||52-Week Range
61.70
+4.28%
Year-to-Date

Today’s Trading

Previous close55.30
Today’s open55.14
Day’s range54.85 - 55.45
Volume7,601,210
Average volume (3 months)10,414,568
Market cap$153.2B
Dividend yield3.34%
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+3.69%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)-7.92%
P/E ratio35.2
Price/Sales3.87
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-6.93-0.85%
NVSNovartis-0.73-0.95%
BMYBristol-Myers Squibb-0.83-1.15%
NVONovo Nordisk-1.14-2.04%
Data as of 05/03/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Partner Offers

Search for Jobs